| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 10 Jan 25 | KYMR Kymera Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 2.08 | 10,000 | 20.80 k | 659,959 |
| 10 Jan 25 | KYMR Kymera Therapeutics | Stock Option Common Stock | Option exercise | Acquire M | No | No | 2.08 | 10,000 | 20.80 k | 495,559 |
| 1 Jul 24 | KYMR Kymera Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 5.33 | 18,773 | 100.06 k | 649,959 |
| 1 Jul 24 | KYMR Kymera Therapeutics | Stock Option Common Stock | Option exercise | Dispose M | No | No | 5.33 | 18,773 | 100.06 k | 288,456 |
| 18 Jun 24 | KYMR Kymera Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 2.08 | 14,413 | 29.98 k | 631,186 |
| 18 Jun 24 | KYMR Kymera Therapeutics | Stock Option Common Stock | Option exercise | Dispose M | No | No | 2.08 | 14,413 | 29.98 k | 505,559 |
| 1 Mar 24 | KYMR Kymera Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 43.5 | 530,000 | 23.06 mm | 530,000 |
| 2 Jan 24 | KYMR Kymera Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 2.08 | 9,000 | 18.72 k | 615,570 |
| 2 Jan 24 | KYMR Kymera Therapeutics | Stock Option Common Stock | Option exercise | Dispose M | No | No | 2.08 | 9,000 | 18.72 k | 519,972 |
